‘Poorly designed’: Indian Council of Medical Research (ICMR) distance itself from BHU study on Covaxin | Delhi News – Times of India

NEW DELHI: Researchers from Banaras Hindu University (BHU) have conducted a one-year follow-up study on individuals who received Bharat Biotech’s Covaxin. The study revealed that approximately one-third of the participants experienced ‘adverse events of special interest’ (AESI) after receiving the vaccine. Dr Rajiv Bahl, the director general of ICMR, has responded to the study by…

Read More

Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects – Times of India

HYDERABAD: After AstraZeneca’s admitted in a UK court that its Covid-19 vaccine caused a rare side-effect — Thrombosis with Thrombocytopenia Syndrome (TTS), Hyderabad-based vaccine maker Bharat Biotech on Thursday stressed on the safety of its indigenous vaccine Covaxin to allay public concerns over Covid vaccines.AstraZeneca’s vaccine Vaxzevria, which it developed in collaboration with Oxford University,…

Read More